Phiwath Jittamas/iStock via Getty Images The following segment was excerpted from Greenhaven Road Capital Main Fund Q1 2025 Investor Letter. Lifecore Biomedical (LFCR) - As previously discussed, Lifecore is a likely beneficiary of the trade policies. Their largest challenge and opportunity is ...